Cargando…
Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non‐small cell lung cancer (NSCLC) via the PI3K/AKT pathway
BACKGROUND: ADAM‐like decysin‐1 (ADAMDEC1) has been reported to play an important role in the pathogenesis of multiple diseases, including cancers. However, its biological role in non‐small cell lung cancer (NSCLC) remains largely unknown. Here, we aimed to investigate the biological functions and p...
Autores principales: | Zhu, Weiliang, Shi, Lin, Gong, Yuxin, Zhuo, Lin, Wang, Siyun, Chen, Shaobing, Zhang, Bei, Ke, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977174/ https://www.ncbi.nlm.nih.gov/pubmed/35178875 http://dx.doi.org/10.1111/1759-7714.14354 |
Ejemplares similares
-
Cancer‐associated fibroblast‐derived exosomal microRNA‐20a suppresses the PTEN/PI3K‐AKT pathway to promote the progression and chemoresistance of non‐small cell lung cancer
por: Shi, Lin, et al.
Publicado: (2022) -
Methyltransferase-like 3 upregulation is involved in the chemoresistance of non-small cell lung cancer
por: Shi, Lin, et al.
Publicado: (2022) -
Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains
por: Plaza-Díaz, Julio, et al.
Publicado: (2017) -
Biological potentials for a family of disintegrin and metalloproteinase (ADAMDEC)-1 in mouse normal pregnancy
por: KUNIYOSHI, Nobue, et al.
Publicado: (2021) -
ADAMDEC1 accelerates GBM progression via activation of the MMP2-related pathway
por: Qi, Huimin, et al.
Publicado: (2022)